133953-35-2 Usage
General Description
2,4-DibroModibenzo[b,d]furan-3-aMine is a chemical compound that belongs to the dibenzofuran class of compounds. It is a brominated derivative of dibenzofuran and contains a primary amine functional group. 2,4-DibroModibenzo[b,d]furan-3-aMine has potential applications in the field of organic synthesis and medicinal chemistry, and its structure makes it an interesting target for research and development. The presence of bromine in the molecule also gives it unique properties that may be useful in certain chemical reactions or as a building block for more complex compounds. Overall, 2,4-DibroModibenzo[b,d]furan-3-aMine is a compound with diverse potential applications and is of interest to researchers in various scientific fields.
Check Digit Verification of cas no
The CAS Registry Mumber 133953-35-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,3,9,5 and 3 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 133953-35:
(8*1)+(7*3)+(6*3)+(5*9)+(4*5)+(3*3)+(2*3)+(1*5)=132
132 % 10 = 2
So 133953-35-2 is a valid CAS Registry Number.
133953-35-2Relevant articles and documents
LUMINESCENT DIAZABENZIMIDAZOLE CARBENE METAL COMPLEXES
-
Page/Page column 191; 192, (2015/02/25)
The present invention relates to metal-carbene complexes of the general formula (I), where variable M is Ir or Pt and that are characterized by variable R being a group of formula (a). The complexes are used in organic electronic devices, especially OLEDs (Organic Light-Emitting Diodes), illuminating elements, stationary visual display units and in material layers as emitter, charge transport material and/or charge or exiton blocker.
The synthesis and anti-MRSA activity of amidinium-substituted 2-dibenzofuranylcarbapenems
Laub, Joanne B.,Greenlee, Mark L.,DiNinno, Frank,Huber, Joann L.,Sundelof, Jon G.
, p. 2973 - 2976 (2007/10/03)
A series of amidinium-substituted 2-dibenzofuranylcarbapenems with potent activity against MRSA has been synthesized via a Stille cross-coupling reaction. These new carbapenems show reduced serum protein binding and improved in vivo efficacy as a conseque
